$2.30
At close: Nov 12, 9:29 AM EDT
$2.35
0.052.17%
After Hours: 9:29 AM EDT
Lexaria Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lexaria Bioscience using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-12 | $-0.13 | $-0.10 | -30.0 % |
Mar 2024 | 2024-04-09 | $-0.06 | $-0.10 | 40.0 % |
Sep 2023 | 2023-11-20 | $-0.12 | $-0.13 | 7.69 % |
Sep 2022 | 2022-11-28 | $-0.24 | $-0.21 | -14.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-12 | $84.00K | $150.00K | -44.0 % |
Sep 2023 | 2023-11-20 | $0 | $170.00K | -100.0 % |
Lexaria Bioscience (LEXX) is scheduled to report earnings on January 10, 2025. The last reported earnings were for reported on July 12, 2024 for Q3.
The Actual EPS was $-0.13, which missed the estimate of $-0.10.
The Actual Revenue was $84K, which missed the estimate of $150K.
Browse earnings estimates, EPS, and revenue on all stocks.